{
    "id": 26678,
    "fullName": "KMT2A - SEPTIN6",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "KMT2A-SEPTIN6 results from the fusion of KMT2A (MLL) and SEPTIN6, resulting in the transformation of myeloid cells in culture and leukemogenesis in mouse models (PMID: 16314519).",
            "references": [
                {
                    "id": 9269,
                    "pubMedId": 16314519,
                    "title": "Disruption of Sept6, a fusion partner gene of MLL, does not affect ontogeny, leukemogenesis induced by MLL-SEPT6, or phenotype induced by the loss of Sept4.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16314519"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4297,
        "geneSymbol": "KMT2A",
        "terms": [
            "KMT2A",
            "ALL-1",
            "CXXC7",
            "HRX",
            "HTRX1",
            "MLL",
            "MLL1",
            "MLL1A",
            "TRX1",
            "WDSTS"
        ]
    },
    "variant": "KMT2A - SEPTIN6",
    "createDate": "07/05/2017",
    "updateDate": "05/17/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 23157,
                "geneSymbol": "SEPTIN6",
                "terms": [
                    "SEPTIN6",
                    "SEP2",
                    "SEPT2",
                    "SEPT6"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 11379,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, I-BET151 and SGC0946 synergistically inhibited proliferation of patient-derived acute myeloid leukemia cells harboring KMT2A-SEPTIN6 in culture (PMID: 27294782).",
            "molecularProfile": {
                "id": 27973,
                "profileName": "KMT2A - SEPTIN6"
            },
            "therapy": {
                "id": 5966,
                "therapyName": "I-BET151 + SGC0946",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9271,
                    "pubMedId": 27294782,
                    "title": "Functional interdependence of BRD4 and DOT1L in MLL leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27294782"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27973,
            "profileName": "KMT2A - SEPTIN6",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}